You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020209028
Dec 20203205
Jan 20215206
Feb 202156015
Mar 202154014
Apr 20212408
May 20211209
Jun 2021008
Jul 20210012
Aug 2021007
Sep 2021007
Oct 202126022
Nov 202136014
Dec 20212405
Jan 20223201
Feb 20224204
Mar 20222802
Apr 20224205
May 20224203
Jun 20223001
Jul 20222801
Aug 202234011
Sep 20222403
Oct 20221600
Nov 20222202
Dec 20223204
Jan 20233601
Feb 20234200
Mar 20232803
Apr 20232802
May 20233807
Jun 20232000
Jul 20231805
Aug 20235205
Sep 20232202
Oct 20232602
Nov 20233203
Dec 20234201
Jan 20242200
Feb 20242600
Mar 20244201
Apr 20242001
May 20243003
Jun 20247400
Jul 20244606
Aug 20242804
Sep 20242001
Oct 20242201
Nov 20242002
Dec 20242004
Jan 20252607
Feb 2025203
Mar 2025003
Apr 2025005
May 2025004
Jun 2025003
Total16790276